For more information click on the link
Harmonex Neuroscience is a clinical research organization, associated with DBMC, specializing in psychiatric and neurological clinical studies in adult and pediatric populations. We have years of experience in conducting clinical trials in a number of indications including ADHD, Bipolar Disorder, Schizophrenia, Depression, Anxiety, Autism and others. Contact us today for more information!
Call: 334-836-2000
Email:
Pre-schoolers ADHD Study with Parent Trianing
Harmonex is conducting a clinical trial for pre-schoolers with ADHD. Any male or female participants 4 to 5 years of age with ADHD are eligible to enroll in this study.
Pre-schoolers ADHD Study without Parent Training
Harmonex is conductiong a clinical trial for pre-schoolers with ADHD. Any male or female participants 4 to 5 years of age with ADHD are eligible to enroll in this study.
Adolescent Schizophrenia Study
Harmonex is conducting a clinical trial for children and adolescents with Schizophrenia. Male and female participants ages 12 - 16 are eligible for this study.
Pediatric and Adolescent Major Depression Study
Harmonex is conducting a clinical trial for children and adolescents with Major Depression. Any male or female participants ages 7 - 17 with Major Depression are eligible for this study.
Adult for Treatment Resistant Major Depression Study
Harmonex is conducting a clinical trial for adults with Treatment Resistant Major Depression. Any male or female participants ages 19- 65 with Treatment Resistant Major Depression are eligible for this study that treats depression with IV medication.
Pediatric and Adolescent Bipolar Study
Harmonex is conducting a clinical trial for children and adolescents with Bipolar Disorder. Any male or female participants 10 to 17 years of age with Bipolar Disorder are eligible to enroll in this study.
Adult Bipolar with Depression Study
Harmonex is conductiong a clinical trial for adults with Bipolar I Depression. Any male or female participants 19 to 65 years of age with Bipolar I Disorder with depression are eligible to enroll in this study.
Child and Adolescent Autism Study
Harmonex is conducting a clinical trial for children and adolescents with Autism. Male and female participants ages 5 - 17 are eligible for this study.
